Schizophrenia Research
Volume 96, Issue 1 , Pages 112-118 , November 2007

Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: A meta-analysis

  • Dawei Li

      Affiliations

    • Bio-X Center, Shanghai Jiao Tong University, Shanghai 200030, China
    • Laboratory of Statistical Genetics, Rockefeller University, New York, 10021, NY, USA
    • Institute for Nutritional sciences, Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
    • Corresponding Author InformationCorresponding authors. Shanghai Jiao Tong University, Bio-X Center, Hao Ran Building, 1954 Hua Shan Road, Shanghai 200030, China, or Institute for Nutritional Sciences, SIBS, Chinese Academy of Sciences, 294 Taiyuan Road, Shanghai 200031, China. Tel./fax: +86 21 62822491.
    • ,
  • Lin He

      Affiliations

    • Institute for Nutritional sciences, Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
    • NHGG Bio-X Center, Shanghai Jiao Tong University, Shanghai 200030, China
    • Corresponding Author InformationCorresponding authors. Shanghai Jiao Tong University, Bio-X Center, Hao Ran Building, 1954 Hua Shan Road, Shanghai 200030, China, or Institute for Nutritional Sciences, SIBS, Chinese Academy of Sciences, 294 Taiyuan Road, Shanghai 200031, China. Tel./fax: +86 21 62822491.

Received 24 April 2007 ,Revised 7 May 2007 ,Accepted 8 May 2007.

References 

  1. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 2001;276:24232–24241
  2. Cho HJ, Meira-Lima I, Cordeiro Q, Michelon L, Sham P, Vallada H, et al. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol. Psychiatry. 2005;10:771–781
  3. Chotai J, Serretti A, Lattuada E, Lorenzi C, Lilli R. Gene–environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms. Psychiatry Res. 2003;119:99–111
  4. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–129
  5. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am. J. Epidemiol. 1995;142:371–382
  6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 1986;7:177–188
  7. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  8. Faraone SV, Taylor L, Tsuang MT. The molecular genetics of schizophrenia: an emerging consensus. Expert. Rev. Mol. Med. 2002;1–13
  9. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 2004;75:891–898
  10. Hall D, Gogos JA, Karayiorgou M. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain. Behav. 2004;3:240–248
  11. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet. 2003;361:417–419
  12. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry. 2005;10:40–68(imgae 45)
  13. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002;21:1539–1558
  14. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, Milev R, et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent–offspring trios from Bulgaria. Biol. Psychiatry. 2004;55:971–975
  15. Kohn Y, Danilovich E, Filon D, Oppenheim A, Karni O, Kanyas K, et al. Linkage disequilibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004;128:65–70
  16. Lee S. From diversity to unity. The classification of mental disorders in 21st-century China. Psychiatr. Clin. North Am. 2001;24:421–431
  17. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am. J. Hum. Genet. 2003;73:34–48
  18. Li D, He L. Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis. Eur. J. Hum. Genet. 2006;14:1130–1135
  19. Li D, He L. Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum. Genet. 2006;119:233–240
  20. Li D, He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet. Med. 2007;9:4–8
  21. Li D, He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics. 2007;175:917–922
  22. Li T, Zhang F, Liu X, Sun X, Sham PC, Crombie C, et al. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol. Psychiatry. 2005;10:1037–1044
  23. Li, D., Collier, D.A., He, L., 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15, 1995–2002.
  24. Liao HM, Chen CH. Mutation analysis of the human dystrobrevin-binding protein 1 gene in schizophrenic patients. Schizophr. Res. 2004;71:185–189
  25. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, et al An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat. Genet. 1995;11:321–324
  26. Morris DW, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, et al. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr. Res. 2003;60:167–172
  27. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20:439–444
  28. Mutsuddi M, Morris DW, Waggoner SG, Daly MJ, Scolnick EM, Sklar P. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am. J. Hum. Genet. 2006;79:903–909
  29. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 2004;13:2699–2708
  30. Owen MJ, Williams NM, O'Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry. 2004;9:14–27
  31. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry. 2005;10:434–449
  32. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 2003;72:185–190
  33. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 2002;71:337–348
  34. Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry. 2002;7:542–559
  35. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 2004;113:1353–1363
  36. Tang JX, Zhou J, Fan JB, Li XW, Shi YY, Gu NF, et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol. Psychiatry. 2003;8:717–718
  37. Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 2003;73:1438–1443
  38. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry. 2003;8:499–510
  39. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry. 2004;61:544–555
  40. Williams M. Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia. Curr. Opin. Investig. Drugs. 2003;4:31–36
  41. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M, et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry. 2004;61:336–344
  42. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 1955;19:251–253

PII: S0920-9964(07)00216-2

doi: 10.1016/j.schres.2007.05.017

Schizophrenia Research
Volume 96, Issue 1 , Pages 112-118 , November 2007

Article Tools

* Image Usage & Resolution